Inhibitory effects of flavonoids on P-glycoprotein in vitro and in vivo: Food/herb-drug interactions and structure-activity relationships

被引:57
作者
Bai, Jie [1 ]
Zhao, Shengyu [1 ]
Fan, Xiaoqing [1 ]
Chen, Yonghui [1 ]
Zou, Xiaowen [1 ]
Hu, Minwan [1 ]
Wang, Baolian [1 ]
Jin, Jing [1 ]
Wang, Xiaojian [1 ]
Hu, Jinping [1 ]
Zhang, Dan [1 ]
Li, Yan [1 ]
机构
[1] Chinese Acad Med Sci, Peking Union Med Coll,State Key Lab Bioact Subst, Inst Mat Med,Beijing Key Lab Nonclin Drug Metab &, Dept Drug Metab,Beijing Key Lab Act Subst Discove, Beijing 100050, Peoples R China
关键词
Flavonoids; P-glycoprotein; Inhibition; Structure-activity relationships; MEDIATED MULTIDRUG-RESISTANCE; CANCER; PHARMACOKINETICS; MECHANISMS; DOXORUBICIN; POLYPHENOLS; PACLITAXEL; MODULATORS; INDUCTION; APOPTOSIS;
D O I
10.1016/j.taap.2019.02.010
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Flavonoids are a class of polyphenol antioxygen, despite various known biological activities and therapeutic potential, scattered but not much is known about their interactions with drug transporters. P-glycoprotein (P-gp) as a cellular defense mechanism by effluxing its substrates has been widely investigated. The aim of this study was to investigate the inhibitory effects of 75 flavonoids on P-gp in vitro and in vivo and to illuminate the structure-activity relationships of flavonoids with P-gp. Five flavonoids, including tangeretin, sinensetin, isosinensetin, sciadopitysin and oroxylin A exhibited significant inhibition on P-gp in MDR1-MDCKIIcells, which reduced the P-gp-mediated efflux of paraquat and taxol and consequently increased their cell toxicity. In addition, co-administration of digoxin with five flavonoids increased the AUC(0-t), of digoxin in different extents in rats, from 19.84% to 81.51%. Molecular docking assays elucidated the inhibitory effect of flavonoids might be related to Pi interactions, but not hydrogen bonds. The pharmacophore model suggested the hydrophobic groups in B benzene ring may play a vital role in the potency of flavonoids inhibition on P-gp. Taken together, our findings would provide the basis for a reliable assessment of the potential risks of flavonoid-containing food/ herb-drug interactions in humans.
引用
收藏
页码:49 / 59
页数:11
相关论文
共 52 条
[1]  
Advani R, 2001, CLIN CANCER RES, V7, P1221
[2]   Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding [J].
Aller, Stephen G. ;
Yu, Jodie ;
Ward, Andrew ;
Weng, Yue ;
Chittaboina, Srinivas ;
Zhuo, Rupeng ;
Harrell, Patina M. ;
Trinh, Yenphuong T. ;
Zhang, Qinghai ;
Urbatsch, Ina L. ;
Chang, Geoffrey .
SCIENCE, 2009, 323 (5922) :1718-1722
[3]   Biochemical, cellular, and pharmacological aspects of the multidrug transporter [J].
Ambudkar, SV ;
Dey, S ;
Hrycyna, CA ;
Ramachandra, M ;
Pastan, I ;
Gottesman, MM .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1999, 39 :361-398
[4]   川陈皮素对P-糖蛋白的体内外抑制作用及分子机制研究 [J].
白洁 ;
赵晟宇 ;
范小庆 ;
姜剑伟 ;
王蕊 ;
邹小文 ;
扈金萍 ;
李燕 .
药学学报, 2018, 53 (05) :754-759
[5]   P-gp Inhibition Potential in Cell-Based Models: Which "Calculation" Method is the Most Accurate? [J].
Balimane, Praveen V. ;
Marino, Anthony ;
Chong, Saeho .
AAPS Journal, 2008, 10 (04) :577-586
[6]   Mammalian ABC transporters in health and disease [J].
Borst, P ;
Elferink, RO .
ANNUAL REVIEW OF BIOCHEMISTRY, 2002, 71 :537-592
[7]   Herb-Drug Interactions: Challenges and Opportunities for Improved Predictions [J].
Brantley, Scott J. ;
Argikar, Aneesh A. ;
Lin, Yvonne S. ;
Nagar, Swati ;
Paine, Mary F. .
DRUG METABOLISM AND DISPOSITION, 2014, 42 (03) :301-317
[8]   Potential Mechanisms of Action of Dietary Phytochemicals for Cancer Prevention by Targeting Cellular Signaling Transduction Pathways [J].
Chen, Hongyu ;
Liu, Rui Hai .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2018, 66 (13) :3260-3276
[9]   Scutellariae radix Induces Apoptosis in Chemoresistant SCC-25 Human Tongue Squamous Carcinoma Cells [J].
Choi, Byul-Bora ;
Choi, Jeong Hae ;
Park, Sang-Rye ;
Kim, Ji-Young ;
Hong, Jin-Woo ;
Kim, Gyoo-Cheon .
AMERICAN JOURNAL OF CHINESE MEDICINE, 2015, 43 (01) :167-181
[10]   Substantial pharmacokinetic interaction between digoxin and ritonavir in healthy volunteers [J].
Ding, R ;
Tayrouz, Y ;
Riedel, KD ;
Burhenne, J ;
Weiss, J ;
Mikus, G ;
Haefeli, WE .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 76 (01) :73-84